TransUnion
TRU
$83.80
+8.49%
TransUnion is one of the three leading credit bureaus in the United States, providing consumer credit information, fraud detection, marketing, and analytical services to businesses and consumers globally. As a core infrastructure provider in the credit ecosystem, it operates in over 30 countries with about 20-25% of revenue from international markets, distinguishing itself through its data assets and analytics capabilities. The current investor narrative centers on its growth acceleration, driven by a 13.7% YoY revenue increase in Q1 2026 and strategic expansion into international markets, including the recent acquisition of majority ownership in Mexico's Buró de Crédito. Debate persists around its ability to sustain margin expansion and navigate competitive pressures from peers like Equifax and Experian, as well as emerging AI-driven lending platforms.…
TRU
TransUnion
$83.80
Related headlines
Investment Opinion: Should I buy TRU Today?
Rating: Buy. TransUnion is a growth-oriented company with accelerating revenue, expanding margins, and a forward P/E that is undervalued relative to peers. The analyst consensus is Buy with an average target of $89.95, implying 17.6% upside.
Supporting evidence includes: (1) Revenue growth of 13.7% YoY in Q1 2026, outpacing the industry average of ~8%; (2) Net margin expansion to 31.9% (though partly one-time), with operating margin at 19.7%; (3) Forward P/E of 13.7x, below the industry average of ~18x; (4) PEG ratio of 0.61, indicating undervaluation relative to growth. Free cash flow TTM is $696.5 million, providing a cushion for debt service and investments.
Key risks that could invalidate the thesis: (1) A slowdown in revenue growth below 10% would compress the forward P/E; (2) Integration challenges with the Buró de Crédito acquisition could pressure margins; (3) Competitive disruption from AI lenders could erode market share. This Buy rating would be downgraded to Hold if revenue growth falls below 10% or if the forward P/E expands above 18x. Overall, TRU appears undervalued relative to its growth trajectory and forward earnings, making it an attractive buy for growth-oriented investors.
Sign up to view all
TRU 12-Month Price Forecast
TransUnion's growth trajectory and valuation support a bullish stance, but confidence is medium due to elevated debt and competitive risks. The forward P/E discount to peers and low PEG ratio suggest the market is underestimating earnings growth. However, the stock's high beta and recent underperformance warrant caution. If revenue growth remains above 12% and margins continue to expand, the stock could re-rate higher. Conversely, any signs of deceleration or margin pressure would prompt a downgrade to neutral. Key catalysts to watch include Q2 earnings and integration updates from the Buró de Crédito acquisition.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on TransUnion's 12-month outlook, with a consensus price target around $89.95 and implied upside of +7.3% versus the current price.
Average Target
$89.95
0 analysts
Implied Upside
+7.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$72 - $108
Analyst target range
TransUnion is covered by 21 analysts, with a consensus recommendation of 'Buy' (mean rating 1.77 on a 1-5 scale, where 1 is Strong Buy). The average target price is $89.95, implying an upside of 17.6% from the current price of $76.51. The distribution leans bullish, with recent ratings from JP Morgan (Overweight), Needham (Buy), and Morgan Stanley (Overweight), while Mizuho, UBS, and BofA maintain Neutral. The target range spans from a low of $72.00 to a high of $108.00, representing a 50% spread between low and high. The high target of $108 implies a 41.2% upside and likely assumes continued revenue acceleration, margin expansion, and successful integration of the Buró de Crédito acquisition. The low target of $72 suggests a 5.9% downside, potentially pricing in competitive pressures or a slowdown in credit demand. The wide spread indicates high uncertainty among analysts, but the overall bullish consensus and recent upgrades (e.g., Goldman Sachs Neutral, but no downgrades) suggest confidence in the company's growth trajectory. The implied upside to the average target supports a positive outlook, though investors should monitor execution risks.
Bulls vs Bears: TRU Investment Factors
TransUnion presents a compelling growth story with accelerating revenue, expanding margins, and a favorable forward valuation. The bull case is supported by strong fundamental momentum, analyst optimism, and a PEG ratio of 0.61 indicating undervaluation relative to growth. However, bears point to a high trailing P/E, elevated debt, and competitive threats from AI-driven lenders. The most critical tension is whether the company can sustain its 13.7% revenue growth and margin expansion to justify the current valuation. If growth decelerates, the stock could face significant multiple compression. Overall, the evidence leans bullish given the forward P/E discount and strong earnings trajectory, but investors should monitor debt levels and competitive dynamics closely.
Bullish
- Revenue Growth Accelerating: Q1 2026 revenue grew 13.7% YoY to $1.246 billion, accelerating from 8.9% in Q1 2025. This outpaces the industry average of ~8%, driven by U.S. Markets and international expansion.
- Strong Margin Expansion: Net margin surged to 31.9% in Q1 2026 from 13.5% a year ago, while operating margin improved to 19.7% from 23.2% (prior year was elevated). The company benefits from high operating leverage typical of data services.
- Undervalued on Forward P/E and PEG: Forward P/E of 13.7x is below the industry average of ~18x, and PEG ratio of 0.61 suggests undervaluation relative to growth. This implies the market is not fully pricing in expected earnings growth.
- Analyst Consensus Buy with Upside: 21 analysts rate TRU a Buy with an average target of $89.95, implying 17.6% upside. The high target of $108 suggests 41.2% potential, reflecting confidence in growth and acquisition synergies.
Bearish
- Trailing P/E Premium to Peers: Trailing P/E of 36.7x is a 67% premium to the industry median of ~22x. This leaves little room for error; any growth disappointment could trigger multiple compression.
- High Debt and Acquisition Spending: Debt-to-equity of 1.16x indicates moderate leverage, and Q1 2026 free cash flow was only $19 million due to $578.6 million in acquisition spending. This limits financial flexibility and increases refinancing risk.
- Underperformance and High Volatility: TRU has underperformed the S&P 500 by 38.7% over the past year, with a beta of 1.545. The stock is 54.5% more volatile than the market, amplifying downside risk in a downturn.
- Competitive Pressure from AI Lenders: Emerging AI-driven lending platforms like Upstart are building proprietary credit models, potentially reducing reliance on traditional credit bureaus. This could erode TRU's market share over time.
TRU Technical Analysis
TransUnion is in a sustained downtrend over the past year, with a 1-year price change of -22.27%, significantly underperforming the S&P 500's +16.47% gain. The current price of $76.51 sits at 43.5% of its 52-week range (low $63.37, high $99.39), indicating it is closer to the low end. This positioning suggests the stock is in a recovery phase from its lows but still far from its highs, reflecting lingering bearish sentiment and potential value opportunity if fundamentals improve. Over the past month, the stock has rallied 12.51%, while the 3-month change is +5.37%, showing short-term momentum accelerating. This divergence from the 1-year downtrend could signal a potential trend reversal or a temporary pullback within a larger bear market. The 1-month relative strength of +11.73% versus the S&P 500 confirms strong near-term outperformance, but the 1-year relative strength of -38.74% underscores persistent weakness. Key support is at the 52-week low of $63.37, a break below which would signal further downside and a potential test of lower levels. Resistance is at the 52-week high of $99.39; a breakout above would indicate a major trend reversal. With a beta of 1.545, TransUnion is 54.5% more volatile than the market, meaning larger price swings and higher risk for position sizing.
Beta
1.54
1.54x market volatility
Max Drawdown
-35.1%
Largest decline past year
52-Week Range
$63-$99
Price range past year
Annual Return
-14.8%
Cumulative gain past year
| Period | TRU Return | S&P 500 |
|---|---|---|
| 1m | +19.1% | +1.6% |
| 3m | +18.9% | +4.1% |
| 6m | +3.9% | +6.8% |
| 1y | -14.8% | +16.3% |
| ytd | +0.6% | +8.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
TRU Fundamental Analysis
Revenue growth is accelerating, with Q1 2026 revenue of $1.2457 billion up 13.69% YoY from $1.0957 billion in Q1 2025, and up from $1.1714 billion in Q4 2025. The trailing twelve-month revenue is approximately $4.724 billion, with consistent sequential growth over the past four quarters. The U.S. Markets segment contributed $975.1 million (78.3% of total) and International $274 million (22.0%), with international expansion a key growth driver. This growth trajectory supports the investment case for a company benefiting from increasing demand for credit data and analytics. Profitability is strong and improving: net income in Q1 2026 was $397.2 million, a sharp increase from $101.2 million in Q4 2025 and $148.1 million in Q1 2025. Gross margin was 58.3% in Q1 2026, stable compared to 59.3% in Q1 2025, while operating margin expanded to 19.65% from 23.22% a year ago (though the prior year was elevated). Net margin surged to 31.89% in Q1 2026 from 13.52% in Q1 2025, driven by a one-time gain? The company is clearly profitable with expanding margins, which is typical for data services firms with high operating leverage. Balance sheet health is moderate: debt-to-equity ratio is 1.16, indicating moderate leverage, while the current ratio of 1.75 suggests adequate liquidity. Free cash flow (TTM) is $696.5 million, but Q1 2026 FCF was only $19 million due to heavy acquisition spending ($578.6 million). ROE is 10.26%, and ROA is 4.65%, showing decent returns on capital. The company generates sufficient cash to fund operations but relies on external financing for large acquisitions, as seen in the Buró de Crédito deal.
Quarterly Revenue
$1.2B
2026-03
Revenue YoY Growth
+13.7%
YoY Comparison
Gross Margin
58.3%
Latest Quarter
Free Cash Flow
$696500000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is TRU Overvalued?
Since net income is positive ($397.2 million in Q1 2026), the primary valuation metric is the P/E ratio. The trailing P/E is 36.65x, while the forward P/E is 13.69x, a significant gap that implies the market expects a sharp earnings increase in the coming year. This forward multiple suggests the market is pricing in robust growth, consistent with the recent revenue acceleration. Compared to the industry average (Specialty Business Services), TransUnion's trailing P/E of 36.65x is at a premium to the sector median of roughly 22x (based on available data), representing a 67% premium. This premium may be justified by its superior growth (13.7% YoY revenue growth vs. industry average of ~8%) and strong margins (net margin 31.9% vs. industry ~15%). However, the forward P/E of 13.69x is actually below the industry forward average of ~18x, suggesting the market may be undervaluing future earnings relative to peers. Historically, TransUnion's trailing P/E has ranged from 5.58x (Q4 2021) to 103.34x (Q1 2022), with the current 36.65x near the middle of its 5-year range. The current P/E is below the 5-year average of approximately 45x, indicating the stock is not excessively overvalued by historical standards. The PEG ratio of 0.61 suggests the stock is undervalued relative to its growth rate, supporting a bullish valuation view.
PE
36.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 6x~75x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: TransUnion's debt-to-equity ratio of 1.16x indicates moderate leverage, and the company's free cash flow in Q1 2026 was only $19 million due to heavy acquisition spending of $578.6 million. This reliance on external financing for growth increases financial risk, especially if interest rates remain elevated. Additionally, the net margin of 31.9% in Q1 2026 was inflated by a one-time gain; normalized margins are lower, and any reversal could pressure earnings. Revenue concentration in the U.S. Markets segment (78.3% of total) exposes the company to domestic economic cycles and credit demand fluctuations.
Market & Competitive Risks: The stock's trailing P/E of 36.7x is a 67% premium to the industry median, making it vulnerable to valuation compression if growth disappoints. With a beta of 1.545, TRU is highly correlated with market movements, and a broad market downturn could amplify losses. Competitive threats from AI-driven lenders like Upstart, which are developing proprietary credit models, could reduce demand for traditional credit bureau data. Recent news highlights that established rivals are building their own AI tools, potentially eroding TransUnion's competitive moat.
Worst-Case Scenario: In a severe recession, credit demand could decline, causing revenue growth to stall and margins to compress. The stock could retest its 52-week low of $63.37, representing a 17.2% downside from the current price of $76.51. If the company faces a debt refinancing crisis or a major competitive disruption, the downside could extend to the historical max drawdown of -35.06%, implying a price near $49.70. In this scenario, an investor could lose up to 35% of their investment from current levels.
FAQ
The key risks include: (1) Financial risk from high debt (D/E 1.16) and low free cash flow in Q1 2026 ($19 million) due to acquisition spending; (2) Valuation risk from a trailing P/E of 36.7x, which could compress if growth disappoints; (3) Competitive risk from AI-driven lenders like Upstart that are building proprietary credit models, potentially reducing demand for traditional credit bureau data; (4) Macro risk from a potential recession that could slow credit demand, with the stock's beta of 1.545 amplifying market downturns. The most severe risk is a growth deceleration below 10%, which could trigger a re-rating toward the 52-week low of $63.37.
The 12-month forecast is moderately bullish, with a base case probability of 50% targeting a price range of $80-$95 (average $89.95). The bull case (30% probability) sees the stock reaching $90-$108, driven by accelerating growth and margin expansion. The bear case (20% probability) projects a decline to $63-$72 if growth slows or competitive pressures intensify. The most likely scenario is the base case, where revenue growth sustains at 12-14% and the stock trades near the analyst average target. Key assumptions include stable credit markets and successful integration of the Buró de Crédito acquisition.
TransUnion appears undervalued on a forward basis but overvalued on a trailing basis. The forward P/E of 13.7x is below the industry average of ~18x, and the PEG ratio of 0.61 suggests the stock is cheap relative to its earnings growth. However, the trailing P/E of 36.7x is a 67% premium to the industry median of 22x, reflecting the market's expectation of strong future earnings. Historically, the stock's 5-year average trailing P/E is ~45x, so the current 36.7x is below that average. Overall, the valuation is reasonable if the company delivers on growth expectations, but it leaves little room for error.
TransUnion presents a compelling buy for growth investors, with a forward P/E of 13.7x that is below the industry average of 18x and a PEG ratio of 0.61 indicating undervaluation relative to its growth rate. The analyst consensus is Buy with an average target price of $89.95, implying 17.6% upside from the current $76.51. However, the trailing P/E of 36.7x is elevated, and the stock has high volatility (beta 1.545) and significant debt (D/E 1.16). It is a good buy for those with a 12-month horizon who believe revenue growth can sustain above 12% and margins can expand. For risk-averse investors, the potential downside to the 52-week low of $63.37 (-17.2%) may be too high.
TransUnion is better suited for long-term investment (3-5 years) given its growth trajectory and essential role in credit infrastructure. The stock's high beta (1.545) and recent volatility make it risky for short-term trading, though the 1-month rally of 12.5% shows potential for tactical plays. The company has a dividend yield of 0.54%, which is minimal, so income investors should look elsewhere. For long-term investors, the forward P/E of 13.7x and PEG of 0.61 offer an attractive entry point, but patience is required to realize the full upside from international expansion and margin improvement. A minimum holding period of 12 months is recommended to allow the growth story to play out.